MedPath
NMPA Approval

Epalrestat Tablets

国药准字H20253534

March 4, 2025

Drug Information

依帕司他片

片剂

50mg

化学药品

March 4, 2025

Company Information

Applicant Company

浙江省台州市椒江区滨海路27号

Manufacturing Company

浙江省台州市椒江区滨海路27号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

依帕司他片 - NMPA 批准文号 | MedPath